Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L) LSE
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.24B |
| Enterprise Value | 3.29B |
| P/E Ratio | 22.84 |
| PEG Ratio | -0.64 |
| Price/Sales Ratio | 4.05 |
| Price/Book Ratio | 4.46 |
| Enterprise/Revenue | 4.07 |
| Enterprise/EBITDA | 15.1 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.18 |
| Operating Margin | 0.23 |
AD
Management Effectiveness
| Return On Assets | 0.14 |
| Return On Equity | 0.21 |
Income Statement
| Revenue | 743.48M |
| Revenue/Share | 14.49 |
| Gross Profit | 451.65M |
| EBITDA | 203.52M |
| Net Income | 140.44M |
| Diluted EPS | 2.75 |
Balance Sheet
| Total Cash | 97.39M |
| Total Cash/Share | 1.9 |
| Total Debt | 114.44M |
| Total Debt/Equity | 0.17 |
| Current Ratio | 3.66 |
| Book Value Per Share | 13.43 |
Price History
| 52-Week Change | 8.7 |
| 52-Week High | 79.76 |
| 52-Week Low | 37.14 |
| Moving Average 50 Days | 67.54 |
| Moving Average 200 Days | 53.85 |
Statistics
| Average Volume | 11,270 |
| Shares Outstanding | 51.15M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.94 |
| Trailing Annual Dividend Yield | 1.59 |
| Payout Ratio | 0.36 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
